Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib 21 July 2020 | 09:46 Code : 10579 New Features Send To Others Your Name Your Email Recipient Email Send Cancel visits:20420 http://http://journal.waocp.org/article_88725.html
